Andrea Discacciati
Papers
1
Total Citations
6
H-Index
1
About
Andrea Discacciati is a leading epidemiologist and biostatistician whose research centers on prostate cancer treatment outcomes, causal inference methods, and evidence synthesis. His most notable contribution is the Prostate Cancer IRE Study (PRIS), a landmark randomized controlled trial comparing focal irreversible electroporation (IRE) to radical treatment for localized prostate cancer. This work addresses a critical clinical question: whether non-thermal focal therapy can effectively treat lesions while preserving surrounding healthy tissue and anatomical structures. The PRIS trial has garnered significant attention (6 citations since 2023) for its potential to shift treatment paradigms toward less invasive approaches. Discacciati's methodological expertise in causal inference has strengthened the validity of observational studies in urologic oncology, enabling more reliable comparisons between treatment strategies. His research portfolio demonstrates a commitment to rigorous study design and patient-centered outcomes, making him a key figure in the ongoing evolution of prostate cancer management toward personalized, function-preserving therapies.
Research Focus
Key Achievements
Top Papers
- 1